Not exact matches
The scientists demonstrated this by
transferring T cells lacking the Tob1
gene into mice that had no immune systems but had
normal Tob1 in all other cells.
Years after receiving a single dose of
gene therapy, patients on the hemophilia B trial continued to produce their own clotting factor from the
normal transferred gene with minimal side effects.
They also found that repetitive parts of the
normal worm genome that look similar to the transgene arrays also behaved in the same way, suggesting that this epigenetic memory
transfer was not restricted just to the artificially engineered
genes.